Ginsenoside Rb1 for Myocardial Ischemia/Reperfusion Injury: Preclinical Evidence and Possible Mechanisms

Non-nuclear estrogen receptor alpha activation in endothelium reduces cardiac ischemia-reperfusion injury in mice

(2017) Sara Menazza et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Salvianolic Acid Exerts Cardioprotection through Promoting Angiogenesis in Animal Models of Acute Myocardial Infarction: Preclinical Evidence

(2017) Long-jie Yu et al.   Oxidative Medicine and Cellular Longevity

Preparation of ginseng extract with enhanced levels of ginsenosides Rg1 and Rb1 using high hydrostatic pressure and polysaccharide hydrolases

(2017) Joo-Won Suh et al.   Pharmacognosy Magazine

The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge

(2016) Gerd Heusch et al.   EUROPEAN HEART JOURNAL

Featured Article: Pharmacological postconditioning with delta opioid attenuates myocardial reperfusion injury in isolated porcine hearts

(2016) Maria Seewald et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

The National Institutes of Health and guidance for reporting preclinical research

(2015) David Moher et al.   BMC Medicine

Cardiovascular pharmacotherapy: Innovation stuck in translation

(2015) Gerard A. Rongen et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Ginsenoside-Rg1 induces angiogenesis by the inverse regulation of MET tyrosine kinase receptor expression through miR-23a

(2015) Hoi-Hin Kwok et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Pivotal Role of Phospholipase D1 in Tumor Necrosis Factor-α–Mediated Inflammation and Scar Formation after Myocardial Ischemia and Reperfusion in Mice

(2014) Tanja Schönberger et al.   AMERICAN JOURNAL OF PATHOLOGY

Towards evidence-based translational research: The pros and cons of conducting systematic reviews of animal studies

(2014) Judith van Luijk   ALTEX-Alternatives to Animal Experimentation

Two Years Later: Journals Are Not Yet Enforcing the ARRIVE Guidelines on Reporting Standards for Pre-Clinical Animal Studies

(2014) David Baker et al.   PLOS BIOLOGY

Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology

(2013) Derek J. Hausenloy et al.   CARDIOVASCULAR RESEARCH

Protective effect of ginsenoside Rg1 on lidocaine-induced apoptosis

(2013) HUI LI et al.   Molecular Medicine Reports

Comparison of Exercise Treadmill Testing With Cardiac Computed Tomography Angiography Among Patients Presenting to the Emergency Room With Chest Pain

(2012) Ron Blankstein et al.   Circulation-Cardiovascular Imaging

Value of Primordial and Primary Prevention for Cardiovascular Disease

(2011) William S. Weintraub et al.   CIRCULATION

Use of ginseng to reduce post-myocardial adverse myocardial remodeling: applying scientific principles to the use of herbal therapies

(2011) Sreedhar Bodiga et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Protective effect of ginsenoside Rb1 against myocardial ischemia/reperfusion injury in streptozotocin-induced diabetic rats

(2010) Yang Wu et al.   MOLECULAR BIOLOGY REPORTS

Why Do We Still Not Have Cardioprotective Drugs?

(2009) James M. Downey et al.   CIRCULATION JOURNAL

Ginseng Compounds: An Update on their Molecular Mechanisms and Medical Applications

(2009) Jian-Ming Lu et al.   Current Vascular Pharmacology

LAD-Ligation: A Murine Model of Myocardial Infarction

(2009) Mandy V.V. Kolk et al.   Jove-Journal of Visualized Experiments

Ginsenoside Rb1 Preconditioning Protects Against Myocardial Infarction After Regional Ischemia and Reperfusion by Activation of Phosphatidylinositol-3-kinase Signal Transduction

(2008) Zhi Wang et al.   CARDIOVASCULAR DRUGS AND THERAPY